{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:51:58Z","timestamp":1791510718183,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF23OC0081911"],"award-info":[{"award-number":["NNF23OC0081911"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\u03b2-hydroxybutyrate (BHB), produced during ketosis, can conjugate with amino acids forming BHB-amino acids. D-BHB-phenylalanine (D-BHB-Phe) is the most abundant BHB-amino acid and has been shown to reduce appetite and induce weight loss in mice, but its function and regulation in humans remain unclear. The objective of this study was to determine whether D-BHB-Phe concentrations vary across different degrees and forms of ketosis in humans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma D-BHB-Phe was measured in samples from four clinical cross-over trials (i) after 21 days on a ketogenic diet (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910), (ii) after oral consumption of 30\u00a0g ketone salt (KS) and 30\u00a0g ketone ester (KE) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914), (iii) after oral KE at doses of 10, 20 and 40\u00a0g (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) and (iv) after oral versus intravenous KS administration (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After 21 days of ketogenic dieting, plasma D-BHB-Phe became detectable (median 2.1 nmol\/L; range 0.9\u201319.9), compared with near-undetectable concentrations during the standard diet (median 0; range 0-0.9;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). Oral KS and KE increased D-BHB-Phe compared with placebo (\n                      <jats:italic>intervention x time<\/jats:italic>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). D-BHB-Phe rose dose-dependently after 10\u00a0g, 20\u00a0g, and 40\u00a0g of KE (\n                      <jats:italic>intervention x time<\/jats:italic>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Oral KS induced higher peak concentrations of D-BHB-Phe (15.6\u2009\u00b1\u20096.4 nmol\/L) compared with iso-ketotic intravenous KS infusion, which elicited only a modest peak (1.5\u2009\u00b1\u20090.3 nmol\/L;\n                      <jats:italic>intervention x time<\/jats:italic>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). A positive association between the D-BHB and D-BHB-Phe concentration was observed in pooled analyses but was not consistent across cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>D-BHB-Phe is inducible by ketosis in humans. Our findings suggest involvement of the splanchnic bed in its production and support further exploration of D-BHB-Phe\u2019s role in appetite regulation and metabolic health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registrations<\/jats:title>\n                    <jats:p>NCT05012748, NCT03935841, NCT05263401, NCT05581043.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12986-026-01172-7","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:16:29Z","timestamp":1784117789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ketosis elevates plasma concentrations of D-\u03b2-hydroxybutyryl-phenylalanine (BHB-Phe) in humans"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-941X","authenticated-orcid":false,"given":"Mette Glavind B\u00fclow","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emaan","family":"Ghias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Bangshaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien Vinh","family":"Loung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Bisgaard","family":"Bengtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Vandsted","family":"Svart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Christian","family":"Gormsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Rittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"1172_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E. \u03b2-Hydroxybutyrate: A Signaling Metabolite. Annu Rev Nutr. 2017;37:51\u201376.","journal-title":"Annu Rev Nutr"},{"key":"1172_CR2","doi-asserted-by":"crossref","unstructured":"M\u00f8ller N. Ketone Body, 3-Hydroxybutyrate: Minor Metabolite - Major Medical Manifestations. J Clin Endocrinol Metab. 2020;105(9):dgaa370 .","DOI":"10.1210\/clinem\/dgaa370"},{"issue":"1","key":"1172_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2024.10.032","volume":"188","author":"MD Moya-Garzon","year":"2025","unstructured":"Moya-Garzon MD, Wang M, Li VL, Lyu X, Wei W, Tung AS, et al. A \u03b2-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites. Cell. 2025;188(1):175\u2013e8620.","journal-title":"Cell"},{"issue":"21","key":"1172_CR4","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1073\/pnas.1424638112","volume":"112","author":"RS Jansen","year":"2015","unstructured":"Jansen RS, Addie R, Merkx R, Fish A, Mahakena S, Bleijerveld OB, et al. N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc Natl Acad Sci U S A. 2015;112(21):6601\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7915","key":"1172_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-022-04828-5","volume":"606","author":"VL Li","year":"2022","unstructured":"Li VL, He Y, Contrepois K, Liu H, Kim JT, Wiggenhorn AL, et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature. 2022;606(7915):785\u201390.","journal-title":"Nature"},{"issue":"3","key":"1172_CR6","doi-asserted-by":"publisher","first-page":"C643","DOI":"10.1152\/ajpcell.00896.2025","volume":"330","author":"A Marcotte-Ch\u00e9nard","year":"2026","unstructured":"Marcotte-Ch\u00e9nard A, Sandilands RE, Teixeira AA, McCarthy SF, Moya-Garzon MD, Goldberg E, et al. Acute ketone monoester ingestion increases monocyte lysine \u03b2-hydroxybutyrylation and plasma \u03b2-hydroxybutyrate amino acid conjugates in humans. Am J Physiol Cell Physiol. 2026;330(3):C643\u201350.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"1172_CR7","doi-asserted-by":"publisher","first-page":"112872","DOI":"10.1016\/j.isci.2025.112872","volume":"28","author":"H Neudorf","year":"2025","unstructured":"Neudorf H, Sandilands RE, Ursel S, Shaba H, Barg D, Tsusaka T, et al. Altered immunometabolic response to fasting in humans living with obesity. iScience. 2025;28(7):112872.","journal-title":"iScience"},{"issue":"1","key":"1172_CR8","doi-asserted-by":"publisher","first-page":"E143","DOI":"10.1152\/ajpendo.00037.2025","volume":"329","author":"E Ghias","year":"2025","unstructured":"Ghias E, Pedersen MGB, Nielsen CB, Bech LV, Modvig IM, Zubanovic NB, et al. Gut lactate increases circulating l-Lac-Phe and key metabolites linked to GLP-1 and human health. Am J Physiol Endocrinol Metab. 2025;329(1):E143\u201350.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1172_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/oby.23967","volume":"32","author":"TV Luong","year":"2024","unstructured":"Luong TV, Pedersen MGB, Abild CB, Cunnane SC, Croteau E, Lauritsen KM, et al. A ketogenic diet lowers myocardial fatty acid oxidation but does not affect oxygen consumption: a study in overweight humans. Obes (Silver Spring). 2024;32(3):506\u201316.","journal-title":"Obes (Silver Spring)"},{"issue":"3","key":"1172_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-025-06614-0","volume":"69","author":"M Bangshaab","year":"2026","unstructured":"Bangshaab M, Bengtsen MB, Smedegaard S, S\u00f8ndergaard E, M\u00f8ller N, Svart MV, et al. Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diab etes: a randomised crossover study. Diabetologia. 2026;69(3):752\u201363.","journal-title":"Diabetologia"},{"issue":"10","key":"1172_CR11","doi-asserted-by":"publisher","first-page":"dgaa483","DOI":"10.1210\/clinem\/dgaa483","volume":"105","author":"N Rittig","year":"2020","unstructured":"Rittig N, Svart M, Thomsen HH, Vestergaard ET, Rehfeld JF, Hartmann B, et al. Oral D\/L-3-Hydroxybutyrate Stimulates Cholecystokinin and Insulin Secretion and Slows Gastric Emptying in Healthy Males. J Clin Endocrinol Metab. 2020;105(10):dgaa483.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1172_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/obr.12230","volume":"16","author":"AA Gibson","year":"2015","unstructured":"Gibson AA, Seimon RV, Lee CM, Ayre J, Franklin J, Markovic TP, et al. Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obes Rev. 2015;16(1):64\u201376.","journal-title":"Obes Rev"},{"issue":"8","key":"1172_CR13","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/dom.14402","volume":"23","author":"ET Vestergaard","year":"2021","unstructured":"Vestergaard ET, Zubanovic NB, Rittig N, M\u00f8ller N, Kuhre RE, Holst JJ, et al. Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men. Diabetes Obes Metab. 2021;23(8):1834\u201342.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"1172_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/oby.22051","volume":"26","author":"BJ Stubbs","year":"2018","unstructured":"Stubbs BJ, Cox PJ, Evans RD, Cyranka M, Clarke K, de Wet H. A Ketone Ester Drink Lowers Human Ghrelin and Appetite. Obes (Silver Spring). 2018;26(2):269\u201373.","journal-title":"Obes (Silver Spring)"},{"issue":"18","key":"1172_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen R, Moller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, et al. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation. 2019;139(18):2129\u201341.","journal-title":"Circulation"},{"issue":"2","key":"1172_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/EJE-19-0710","volume":"182","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Nilsson M, Ingerslev JS, Olsen DA, Fenger M, Svart M, et al. Effects of \u03b2-hydroxybutyrate on cognition in patients with type 2 diabetes. Eur J Endocrinol. 2020;182(2):233\u201342.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1172_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","volume":"25","author":"MA Reger","year":"2004","unstructured":"Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004;25(3):311\u20134.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1172_CR18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/advances\/nmac036","volume":"13","author":"K Falkenhain","year":"2022","unstructured":"Falkenhain K, Daraei A, Forbes SC, Little JP. Effects of Exogenous Ketone Supplementation on Blood Glucose: A Systematic Review and Meta-analysis. Adv Nutr. 2022;13(5):1697\u2013714.","journal-title":"Adv Nutr"},{"issue":"3","key":"1172_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol. 2012;63(3):401\u20138.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1172_CR20","unstructured":"Gubra. Gubra Gene Expression Experience 2025 [Available from: https:\/\/rnaseq.gubra.dk ]"},{"issue":"5","key":"1172_CR21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/cpt.2382","volume":"110","author":"N Rittig","year":"2021","unstructured":"Rittig N, Aagaard NK, Sundelin E, Villadsen GE, Sandahl TD, Holst JJ, et al. Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single-Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent. Clin Pharmacol Ther. 2021;110(5):1329\u201336.","journal-title":"Clin Pharmacol Ther"},{"key":"1172_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1476-5381.1992.tb09093.x","volume":"105","author":"CJ Bailey","year":"1992","unstructured":"Bailey CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol. 1992;105:1009\u201313.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1172_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","volume":"8","author":"A Yerevanian","year":"2019","unstructured":"Yerevanian A, Soukas AA. Metformin: Mechanisms in Human Obesity and Weight Loss. Curr Obes Rep. 2019;8(2):156\u201364.","journal-title":"Curr Obes Rep"},{"key":"1172_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-med-051013-110046","volume":"66","author":"V Vallon","year":"2015","unstructured":"Vallon V. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med. 2015;66:255\u201370.","journal-title":"Annu Rev Med"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01172-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01172-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01172-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:37:52Z","timestamp":1791509872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-026-01172-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1186\/s12986-026-01172-7","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All four studies were approved by the Central Denmark Regional Scientific Ethics Committee. All participants gave oral and written informed consent to study participation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.M and M.J are co-founders and shareholders of Mmimetika Biosciences ApS. The remaining authors have nothing to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"120"}}